Vanguard Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Sell |
9,379,851
-2,725,569
| -23% | -$9.43M | ﹤0.01% | 2325 |
|
|
2025
Q1 | $31.7M | Sell |
12,105,420
-2,924,789
| -19% | -$7.66M | ﹤0.01% | 2289 |
|
|
2024
Q4 | $61.9M | Buy |
15,030,209
+566,595
| +4% | +$2.33M | ﹤0.01% | 2075 |
|
|
2024
Q3 | $102M | Buy |
14,463,614
+2,758,748
| +24% | +$19.5M | ﹤0.01% | 1860 |
|
|
2024
Q2 | $76.3M | Sell |
11,704,866
-110,803
| -0.9% | -$722K | ﹤0.01% | 1964 |
|
|
2024
Q1 | $98.1M | Buy |
11,815,669
+1,165,282
| +11% | +$9.67M | ﹤0.01% | 1878 |
|
|
2023
Q4 | $117M | Buy |
10,650,387
+98,025
| +0.9% | +$1.08M | ﹤0.01% | 1781 |
|
|
2023
Q3 | $88.7M | Buy |
10,552,362
+23,795
| +0.2% | +$200K | ﹤0.01% | 1872 |
|
|
2023
Q2 | $132M | Buy |
10,528,567
+29,053
| +0.3% | +$365K | ﹤0.01% | 1694 |
|
|
2023
Q1 | $173M | Buy |
10,499,514
+115,296
| +1% | +$1.9M | ﹤0.01% | 1527 |
|
|
2022
Q4 | $155M | Buy |
10,384,218
+2,024,698
| +24% | +$30.2M | ﹤0.01% | 1575 |
|
|
2022
Q3 | $187M | Buy |
8,359,520
+1,261,066
| +18% | +$28.2M | 0.01% | 1424 |
|
|
2022
Q2 | $119M | Buy |
7,098,454
+880,831
| +14% | +$14.8M | ﹤0.01% | 1714 |
|
|
2022
Q1 | $186M | Buy |
6,217,623
+19,181
| +0.3% | +$574K | ﹤0.01% | 1601 |
|
|
2021
Q4 | $190M | Buy |
6,198,442
+1,314,405
| +27% | +$40.4M | ﹤0.01% | 1642 |
|
|
2021
Q3 | $154M | Buy |
4,884,037
+590,595
| +14% | +$18.6M | ﹤0.01% | 1749 |
|
|
2021
Q2 | $157M | Buy |
4,293,442
+242,361
| +6% | +$8.87M | ﹤0.01% | 1758 |
|
|
2021
Q1 | $140M | Buy |
4,051,081
+2,330,406
| +135% | +$80.6M | ﹤0.01% | 1772 |
|
|
2020
Q4 | $71.5M | Buy |
1,720,675
+88,701
| +5% | +$3.69M | ﹤0.01% | 2016 |
|
|
2020
Q3 | $69.5M | Buy |
+1,631,974
| New | +$69.5M | ﹤0.01% | 1852 |
|